NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Start Multiple Choice Practice Test
Start Flash Cards

Practice this question and more.

Triumeq is a first line treatment containing which of the following?

  1. Dolutegravir/abacavir/lamivudine

  2. Elvitegravir/cobibistat/emtricitabine/TAF

  3. Efavirenz/emtricitabine/TDF

  4. Dolutegravir/lamivudine

The correct answer is: Dolutegravir/abacavir/lamivudine

Triumeq is a first line treatment for HIV that contains a combination of three drugs dolutegravir, an integrase inhibitor; abacavir, a nucleoside reverse transcriptase inhibitor; and lamivudine, another nucleoside reverse transcriptase inhibitor. Option A is the only choice that includes all three of these medications. Option B contains four drugs, including Tenofovir Alafenamide (TAF), which is not one of the ingredients in Triumeq. Option C contains Efavirenz, a non-nucleoside reverse transcriptase inhibitor, and Tenofovir Disoproxil Fumarate (TDF), which is also not included in Triumeq. Option D only has two of the three required medications (dolutegravir and lamivudine), making it an incomplete answer. Therefore, option A is the correct choice as it contains all three components of Triumeq, making it a true first line treatment option.

More Questions Like This